QC
IRD

Quadrature Capital’s Opus Genetics IRD Stock Holding History

Quadrature Capital’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Buy
+46,389
New +$216K ﹤0.01% 1368

Other funds holding IRD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Quadrature Capital's IRD Position: Q2 2026 in Review

Quadrature Capital opened a new position in Opus Genetics (IRD) in Q2 2026: 46,389 shares worth $191K. The stake represents ﹤0.01% of the portfolio and ranks #1368 among its holdings.

25 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Quadrature Capital held 46,389 shares of Opus Genetics worth $191K as of Q2 2026.
  • Opus Genetics was a new Quadrature Capital position in Q2 2026.
  • Opus Genetics made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1368 holding.
  • 25 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.